Last reviewed · How we verify
Creatine Monohydrate, Conjugated Linoleic Acid — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Creatine Monohydrate, Conjugated Linoleic Acid (Creatine Monohydrate, Conjugated Linoleic Acid) — Hamilton Health Sciences Corporation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Creatine Monohydrate, Conjugated Linoleic Acid TARGET | Creatine Monohydrate, Conjugated Linoleic Acid | Hamilton Health Sciences Corporation | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Creatine Monohydrate, Conjugated Linoleic Acid CI watch — RSS
- Creatine Monohydrate, Conjugated Linoleic Acid CI watch — Atom
- Creatine Monohydrate, Conjugated Linoleic Acid CI watch — JSON
- Creatine Monohydrate, Conjugated Linoleic Acid alone — RSS
Cite this brief
Drug Landscape (2026). Creatine Monohydrate, Conjugated Linoleic Acid — Competitive Intelligence Brief. https://druglandscape.com/ci/creatine-monohydrate-conjugated-linoleic-acid. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab